Angiomatoid metastatic melanoma.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000473:pathology* / Q000628:therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy*; D013514:Surgical Procedures, Operative / Q000379:methods; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D016898:Interferon-alpha; D003606:Dacarbazine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor